Patient Awareness, Innovation, & Technology: Why these Components are Vital to Performance within a Clinical Trial
$79.00 (Non-Member Price)
$0.00 (SCRS members – Included as member benefit, no additional cost)
Archived webinars do not provide contact hour credits.
As our industry continues to evolve, the “Patient’s Voice” has become a more recognizable and integral part of the clinical development process. However, as we look ahead and continue to find efficient ways to bring forth new medicines and therapies to market, we as an industry, need to continue to challenge ourselves by evaluating existing and innovative approaches to support or enhanced study execution. So how can the voice of the patient contribute to fulfilling these healthcare milestones? Why are patient awareness, innovation, and technology vital to the performance of a clinical trial?
- Categorize areas in which the “Patient Voice” can be incorporated to drive site efficiencies
- Evaluate ways in which innovation and technology can be leveraged to assist or enhance site engagement with patients
- Determine what patients find to be the most important, what motivates a patient to enroll in a study
Associate Director, Site and Patient Access, INC Research/inVentiv Health
Vice President, Segal Trials
Executive Vice President, HealthUnlocked
Advisor, Clinical Innovation, Eli Lilly and Company
T.J. Sharpe is a Stage IV melanoma patient who shares his journey through cancer in the Patient #1 Blog on http://www.philly.com/patient1/, on www.SkinCancer.net, and on www.NovartisOncology.com. He was diagnosed in August 2012 with melanoma tumors in multiple organs, only four weeks after his second child was born. Since then, he has undergone six surgeries and four immunotherapy treatments over two different clinical trials. The initial failures, and subsequent complete response, have been chronicled in his blog posts since December 2012. In addition to writing, he is a keynote speaker and consultant to the biopharma and clinical research industries, bringing an educated patient voice as a true stakeholder in challenging healthcare’s status and making a difference in patients’ lives via his company, Starfish Harbor LLC. A South Jersey native, T.J. lives in Fort Lauderdale, FL, with his wife Jennifer and two young children, Josie and Tommy.
Bonnie Segal is the Vice President and Co-Founder of Segal Trials. She also holds the position of Vice President for each of the 6 affiliated site entities that Segal Trials represent. These entities specialize in Psychiatry, Addiction, Women’s Health and General Medicine. Bonnie has been in medical research for 18 years and has been involved in every area of Segal Trials’ expansion and diversification. She leads the business development, operations, and recruitment teams, as well as the company’s community advocacy initiatives, staff engagement, and staff leadership programs. Bonnie has been a crucial part of the success of over 1,000 clinical trials conducted by the 6 affiliated site entities at 9 research locations throughout South Florida and South Carolina. Bonnie began her healthcare career in 1993 founding Positive Aging, a company specializing in psychiatric services for individuals residing in long-term care facilities. After the sale of Positive Aging, she started and sold another healthcare company, Essentials in Psychology before co-founding Segal Trials in 1998. Bonnie has a Bachelor of Science in Advertising from the University of Florida. Bonnie currently is on the CISCRP (The Center for Information and Study on Clinical Research Participation) advisory board and on the CNS Summit Leadership Council.
Phil Golz is a healthcare entrepreneur and business leader, currently heading HealthUnlocked Inc, the US arm of a prominent social network for health headquartered in the UK. Phil has spent over 15 years working in healthcare environments predominantly within the Pharma industry, where he worked in many different areas of medicine development and commercialization, but always with a focus on technology, innovation, and patient centricity. Since joining HealthUnlocked in 2015, Phil has been instrumental in bringing Pharma, CROs, and Payors closer to patients by establishing a set of services and solutions at HealthUnlocked, which address some of the major issues connected with running studies and provisioning care. Phil shares HealthUnlocked’s vision of driving better health outcomes through patient empowerment and engagement.
Kelly Johnston McKee is a clinical trial innovator and problem solver with a focus on patient recruitment and engagement. As a leader in the Clinical Innovation group at Eli Lilly and Company, she is responsible for the design and successful deployment of game-changing strategies and tactics worldwide. Kelly has been in the industry for over 18 years with previous positions at Merck and Sanofi-Aventis. She has an in-depth understanding and application of novel tactics and technology in protocol feasibility, site selection, and patient recruitment. Kelly was named Pharma Times US Clinical Researcher of the Year in 2012 in the clinical research team category.
Please note: SCRS will send out information on how to access the webinar on the morning of the event.
Society for Clinical Research Sites, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
To obtain your Contact Hours for this webinar:
- The webinar must be watched in its entirety.
- The post-webinar survey immediately following this webinar must be completed in its entirety.
- Your contact hour certificate will be sent to you within 30 days of you viewing this webinar.
- The contact hour certificate will be sent to the email address provided when you registered.
Planners, presenters, faculty, authors, and content reviewers do not have any relevant financial relationships with any commercial interest.
This webinar does not imply any endorsement of products or services by the Society for Clinical Research Sites or ANCC.
The materials and recording of this webinar will be available for one year as an archive, but will not award any contact hours.